BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20634474)

  • 1. Homocysteine in vascular Behcet disease: a meta-analysis.
    La Regina M; Orlandini F; Prisco D; Dentali F
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2067-74. PubMed ID: 20634474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma homocysteine level and uveitis in Behçet's disease.
    Okka M; Oztürk M; Kockar MC; Bavbek N; Rasier Y; Gunduz K
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):931-4. PubMed ID: 12455183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine: an activity marker in Behçet's disease?
    Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homocysteine level in patients with Behcet's disease with or without thrombosis.
    Shahram F; Faridar A; Hamedani MG; Nadji A; Naderi N; Mojarad Shafiee N; Rasker JJ; Davatchi F
    Arch Iran Med; 2010 Nov; 13(6):476-81. PubMed ID: 21039001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced risk of thrombotic disease in patients with acquired vitamin B12 and/or folate deficiency: role of hyperhomocysteinemia.
    Remacha AF; Souto JC; Rámila E; Perea G; Sarda MP; Fontcuberta J
    Ann Hematol; 2002 Nov; 81(11):616-21. PubMed ID: 12454698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum homocysteine level is higher in Behçet's disease with vascular involvement.
    Ateş A; Aydintuğ O; Olmez U; Düzgün N; Duman M
    Rheumatol Int; 2005 Jan; 25(1):42-4. PubMed ID: 14586553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection.
    Arauz A; Hoyos L; Cantú C; Jara A; Martínez L; García I; Fernández Mde L; Alonso E
    Cerebrovasc Dis; 2007; 24(2-3):210-4. PubMed ID: 17596690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia and venous thrombosis: a meta-analysis.
    den Heijer M; Rosendaal FR; Blom HJ; Gerrits WB; Bos GM
    Thromb Haemost; 1998 Dec; 80(6):874-7. PubMed ID: 9869152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
    Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
    Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prevalence of hyperhomocysteinemia in cervical artery dissection causing stroke: a case-control study.
    Benninger DH; Herrmann FR; Georgiadis D; Kretschmer R; Sarikaya H; Schiller A; Baumgartner RW
    Cerebrovasc Dis; 2009; 27(3):241-6. PubMed ID: 19176957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
    Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J
    Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.
    de Souza AW; Silva NP; de Carvalho JF; D'Almeida V; Noguti MA; Sato EI
    Lupus; 2007; 16(10):782-7. PubMed ID: 17895300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study.
    Romagnuolo J; Fedorak RN; Dias VC; Bamforth F; Teltscher M
    Am J Gastroenterol; 2001 Jul; 96(7):2143-9. PubMed ID: 11467646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.
    Houman MH; Naffati H; Khanfir M; Ghannouchi M; Ben Ghorbel I; Lamloum M; El Matri L; Hamzaoui K; Jeddi A; Miled M; Fki M
    Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinaemia in Behçet's disease.
    Aksu K; Turgan N; Oksel F; Keser G; Ozmen D; Kitapçioğlu G; Gümüşdiş G; Bayindir O; Doğanavşargil E
    Rheumatology (Oxford); 2001 Jun; 40(6):687-90. PubMed ID: 11426028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The mechanisms of hyperhomocysteinemia in coronary heart disease].
    Gao W; Jiang N; Zhu G
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):821-3. PubMed ID: 11038775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
    Zoccolella S; Simone IL; Lamberti P; Samarelli V; Tortelli R; Serlenga L; Logroscino G
    Neurology; 2008 Jan; 70(3):222-5. PubMed ID: 18195267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.